| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Assessing the clinical impact of prognostic factors: When is "statistically significant" clinically useful?
|
Hayes, Daniel F.
|
|
1998
|
52 |
1-3 |
p. 305-319
|
artikel
|
| 2 |
Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis
|
Heimann, Ruth
|
|
1998
|
52 |
1-3 |
p. 147-158
|
artikel
|
| 3 |
Authors index
|
|
|
1998
|
52 |
1-3 |
p. 333
|
artikel
|
| 4 |
c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients
|
De Placido, Sabino
|
|
1998
|
52 |
1-3 |
p. 55-64
|
artikel
|
| 5 |
Circulating tumor markers in breast cancer: Accepted utilities and novel prospects
|
Stearns, Vered
|
|
1998
|
52 |
1-3 |
p. 239-259
|
artikel
|
| 6 |
Clinical significance of angiogenic factors in breast cancer
|
Locopo, Nathalia
|
|
1998
|
52 |
1-3 |
p. 159-173
|
artikel
|
| 7 |
Cyclin D1 in Breast Cancer
|
Barnes, Diana M.
|
|
1998
|
52 |
1-3 |
p. 1-15
|
artikel
|
| 8 |
Cyclins and breast cancer
|
Steeg, Patricia S.
|
|
1998
|
52 |
1-3 |
p. 17-28
|
artikel
|
| 9 |
Her-2/neu as a Predictive Marker of Response to Breast Cancer Therapy
|
Pegram, Mark D.
|
|
1998
|
52 |
1-3 |
p. 65-77
|
artikel
|
| 10 |
Insulin-like growth factors in human breast cancer
|
Ellis, Matthew J.
|
|
1998
|
52 |
1-3 |
p. 175-184
|
artikel
|
| 11 |
Matrix metalloproteinase inhibitors
|
Brown, Peter D.
|
|
1998
|
52 |
1-3 |
p. 125-136
|
artikel
|
| 12 |
Metalloproteinases and tissue inhibitors of metalloproteinases
|
Toi, Masakazu
|
|
1998
|
52 |
1-3 |
p. 113-124
|
artikel
|
| 13 |
Methodological challenges in the evaluation of prognostic factors in breast cancer
|
Altman, Douglas G.
|
|
1998
|
52 |
1-3 |
p. 289-303
|
artikel
|
| 14 |
Molecular prognostic markers in breast cancer
|
Dahiya, Rajvir
|
|
1998
|
52 |
1-3 |
p. 185-200
|
artikel
|
| 15 |
Prognostic and predictive value of p53 and p21 in breast cancer
|
Elledge, Richard M.
|
|
1998
|
52 |
1-3 |
p. 79-98
|
artikel
|
| 16 |
Prognostic implications of expression of the cell cycle inhibitor protein p27Kip1
|
Cariou, Sandrine
|
|
1998
|
52 |
1-3 |
p. 29-41
|
artikel
|
| 17 |
Prognostic significance of micrometastatic bone marrow involvement
|
Braun, Stephan
|
|
1998
|
52 |
1-3 |
p. 201-216
|
artikel
|
| 18 |
Prognostic variables in node-negative and node-positive breast cancer - editorial
|
Gasparini, Giampietro
|
|
1998
|
52 |
1-3 |
p. 321-331
|
artikel
|
| 19 |
Subject index
|
|
|
1998
|
52 |
1-3 |
p. 335-337
|
artikel
|
| 20 |
The 67 kDa laminin receptor as a prognostic factor in human cancer
|
Ménard, Sylvie
|
|
1998
|
52 |
1-3 |
p. 137-145
|
artikel
|
| 21 |
The relationship between prognostic and predictive factors in the management of breast cancer
|
Henderson, I. Craig
|
|
1998
|
52 |
1-3 |
p. 261-288
|
artikel
|
| 22 |
The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer
|
Gullick, William John
|
|
1998
|
52 |
1-3 |
p. 43-53
|
artikel
|
| 23 |
The urokinase plasminogen activator system as a target for prognostic studies in breast cancer
|
Stephens, Ross W.
|
|
1998
|
52 |
1-3 |
p. 99-111
|
artikel
|
| 24 |
Time-dependence of hazard ratios for prognostic factors in primary breast cancer
|
Hilsenbeck, Susan G.
|
|
1998
|
52 |
1-3 |
p. 227-237
|
artikel
|
| 25 |
Timing of surgery for primary breast cancer with regard to the menstrual phase and prognosis
|
Jatoi, Ismail
|
|
1998
|
52 |
1-3 |
p. 217-225
|
artikel
|
Tijdschrift beschrijving